0 NASDAQ Companies - November 14, 2024ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational MilestonesABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year. Incremental Payments […]Read More
0 NASDAQ Companies - November 14, 2024EuroDry Ltd. Sets Date for the Release of Third Quarter 2024 Results, Conference Call and WebcastATHENS, Greece, Nov. 14, 2024 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator […]Read More
0 NYSE Companies - November 14, 2024Gabelli Healthcare & WellnessRx Trust Declares Fourth Quarter Distribution of $0.15 Per ShareRYE, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) — The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE: […]Read More
0 NASDAQ Companies - November 14, 2024LPL Financial Welcomes Prosperity Investment ManagementSAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC, announced today that the financial advisors at Prosperity Investment […]Read More
0 NYSE Companies - November 14, 2024Gamco Natural Resources, Gold & Income Trust Declares Monthly Distributions of $0.04 Per ShareRYE, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) — The Board of Trustees of GAMCO Natural Resources, Gold & Income Trust […]Read More
0 NYSE Companies - November 14, 2024Gabelli Global Small and Mid Cap Value Trust Declares Fourth Quarter Distribution of $0.16 per ShareRYE, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) — The Board of Trustees of The Gabelli Global Small and Mid Cap […]Read More
0 NYSE Companies - November 14, 2024The GDL Fund Declares Fourth Quarter Distribution of $0.12 Per ShareRYE, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) — The Board of Trustees of The GDL Fund (NYSE:GDL) (the “Fund”) declared […]Read More
0 NASDAQ Companies - November 14, 2024Envoy Medical Reports Third Quarter 2024 Results and Other Exciting EventsWHITE BEAR LAKE, Minn., Nov. 14, 2024 (GLOBE NEWSWIRE) — Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing […]Read More
0 NASDAQ Companies - November 14, 2024Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity— Transformative Financing worth up to $275 million from Top-Tier Institutional Healthcare Investors — — Advancement of IkT-001Pro into a […]Read More
0 NASDAQ Companies - November 14, 2024BTCS Reports 2024 Q3 Results134% quarterly year-over-year revenue growth Silver Spring, MD, Nov. 14, 2024 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or […]Read More